Literature DB >> 6574799

The analgesic effects of morphine, but not those of the enkephalinase inhibitor thiorphan, are enhanced in arthritic rats.

V Kayser, G Guilbaud.   

Abstract

The effects of various i.v. doses of morphine (0.1, 0.3 and 1 mg/kg) and of thiorphan, an inhibitor of enkephalinase (0.7, 2.5, 5, 10 and 15 mg/kg), were studied upon the vocalization threshold to foot pressure in normal rats and rats with Freund's adjuvant-induced arthritis. The vocalization threshold in arthritic rats was, before any injections, significantly lower than in normal rats (mean pressure threshold for vocalization: 115.2 g +/- 14.7 (n = 152) for arthritic rats vs 182.5 g +/- 21.3 for normal rats (n = 152). The various doses of morphine in raising the vocalization threshold were more efficient in arthritic than in normal rats (maximum vocalization threshold (% of control) following 1 mg/kg morphine = 225.70 +/- 10.21 in arthritic rats vs 140.75 +/- 6.87 in normal rats, n = 9 in each case). This effect was dose-dependent, and in every case, naloxone-reversible. Injected at doses of 5-15 mg/kg, thiorphan increased the vocalization threshold (maximum = 223.91% +/- 11.96 in arthritic rats vs 223.30% +/- 5.93 in normal rats for 15 mg/kg i.v., n = 9 for each group). This effect was not greater in arthritic than in normal rats. The dose of 2.5 mg/kg of thiorphan was insufficient. Administered at 0.7 mg/kg, thiorphan significantly decreased the vocalization threshold in the arthritic rats only. These effects of thiorphan were all naloxone-reversible using doses of naloxone which were one-hundredth of those of thiorphan.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6574799     DOI: 10.1016/0006-8993(83)91046-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  19 in total

1.  The analgesic effects of supraspinal mu and delta opioid receptor agonists are potentiated during persistent inflammation.

Authors:  R W Hurley; D L Hammond
Journal:  J Neurosci       Date:  2000-02-01       Impact factor: 6.167

2.  Evidence for analgesia mediated by peripheral opioid receptors in inflamed synovial tissue.

Authors:  A J Lawrence; G P Joshi; A Michalkiewicz; W P Blunnie; D C Moriarty
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

3.  Persistent pain model reveals sex difference in morphine potency.

Authors:  Xiaoya Wang; Richard J Traub; Anne Z Murphy
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-02-23       Impact factor: 3.619

4.  Spinal and peripheral mechanisms involved in the enhancement of morphine analgesia in acutely inflamed mice.

Authors:  Sara González-Rodríguez; Agustín Hidalgo; Ana Baamonde; Luis Menéndez
Journal:  Cell Mol Neurobiol       Date:  2009-08-05       Impact factor: 5.046

Review 5.  Respiratory depression and brain hypoxia induced by opioid drugs: Morphine, oxycodone, heroin, and fentanyl.

Authors:  Eugene A Kiyatkin
Journal:  Neuropharmacology       Date:  2019-02-05       Impact factor: 5.250

6.  The effect of lysine acetylsalicylate on joint capsule mechanoreceptors in rats with polyarthritis.

Authors:  G Guilbaud; A Iggo
Journal:  Exp Brain Res       Date:  1985       Impact factor: 1.972

7.  Sensory receptors in ankle joint capsules of normal and arthritic rats.

Authors:  G Guilbaud; A Iggo; R Tegnér
Journal:  Exp Brain Res       Date:  1985       Impact factor: 1.972

8.  Spinal opioid analgesia: how critical is the regulation of substance P signaling?

Authors:  J A Trafton; C Abbadie; S Marchand; P W Mantyh; A I Basbaum
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

9.  Cholecystokinin as a factor in the enhanced potency of spinal morphine following carrageenin inflammation.

Authors:  L C Stanfa; A H Dickenson
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

10.  Initial nociceptive sensitization in carrageenin-induced rat paw inflammation is dependent on amine autacoid mechanisms: electrophysiological and behavioural evidence obtained with a quaternary antihistamine, thiazinamium.

Authors:  A Neil; J M Benoist; V Kayser; G Guilbaud
Journal:  Exp Brain Res       Date:  1987       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.